Yann Echelard - 12 Jun 2025 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
Director
Signature
/s/ Yann Echelard
Issuer symbol
TGTX
Transactions as of
12 Jun 2025
Transactions value $
-$369,400
Form type
4
Filing time
16 Jun 2025, 17:47:20 UTC
Previous filing
07 Nov 2024
Next filing
25 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Echelard Yann Director 3020 CARRINGTON MILL BLVD, SUITE 475, MORRISVILLE /s/ Yann Echelard 16 Jun 2025 0001561958

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX Common Stock Award $0 +14.7K +6.57% $0.00 239K 12 Jun 2025 Direct F1, F2
transaction TGTX Common Stock Sale -$369K -10K -4.19% $36.94 229K 13 Jun 2025 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted shares that will vest on June 12, 2026.
F2 Includes shares of restricted Common Stock, which vest over various time periods.
F3 These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Echelard's income tax obligations.
F4 Includes a weighted average price for shares sold in multiple transactions at prices ranging from $36.93 through $36.96, inclusive. Mr. Echelard undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.